Leading US and Korean researchers to apply artificial intelligence to aging research

Friday, 3rd of February, 2017, Baltimore, MD - Insilico Medicine today announced that it signed a Memorandum of Understanding (MOU) and started the first collaborative research project with one of the largest research and medical networks, Gachon University and Gil Medical Center. The intent of the long-term collaboration is to develop artificially intelligent multimodal biomarkers of aging and health status as well as interventions intended to slow down or even reverse the processes leading to the age-related loss of function. "We are happy to collaborate with Insilico Medicine, one of the leaders in AI with a specific focus on practical aging research in the pharmaceutical and healthcare industries. The field of artificial intelligence is rapidly evolving and in addition to our own cutting-edge research programs, we collaborate with other leaders to expedite progress and ensure that we can save and extend human life sooner", said Dr. Lee Uhn, Director of AI-based Precision Medicine at Gachon University, Gil Medical Center. The first MOU between the companies was signed on November 18th, but the first project launched and data exchange transpired in January 2017.